Depression :: Requests for medications boost prescribing for depression

Researchers funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health, have found that requests from patients for medications have a “profound effect” on physicians prescribing for major depression and adjustment disorder. These findings indicate that direct-to-consumer (DTC) marketing of prescription medications for depression may exert significant influence on treatment decisions.

Asthma :: Therapy for Mild Persistent Asthma

Some adults with mild persistent asthma may be able to adequately control their asthma by taking corticosteroids only when needed, instead of taking anti-inflammatory medication daily, according to new results from the Improving Asthma Control Trial (IMPACT). Conducted by the National Heart, Lung, and Blood Institute?s (NHLBI) Asthma Clinical Research Network, the one-year, multi-center study found that participants who were treated with corticosteroids intermittently based on symptoms had about the same rate of severe exacerbations and of asthma-related lung function decline as those treated with the standard recommendation of daily long-term control medication.

Neurology :: Golfers’ Yips May Be Movement Disorder

Yips, a condition that plagues professional and amateur golfers alike and leaves them unable to complete a stroke, may be a movement disorder similar to writer’s cramp and musician’s cramp, researchers reported this week.

Vitamin E :: Take it easy with vitamin E

Vitamin E is one of the most widely used supplements, taken regularly by nearly a quarter of adults ages 55 and over. But recent research suggests that it may not do as much good in preventing cancer and other diseases as once thought, and it might actually cause harm.

Medication :: Lessons from the COX-2 saga

By the beginning of this year, a consensus had developed on the link between COX-2 drugs and heart disease risk: The evidence for cardiovascular side effects was strongest for Vioxx and Bextra, intermediate for Celebrex, and weak for naproxen. An overview article in the March issue of the Harvard Health Letter explains this consensus, and can serve as a base of information that readers can turn to as this story continues to unfold.

Breast cancer :: Preventive mastectomy removes breast cancer risk

A new study provides more evidence that women who are at increased risk of developing breast cancer can significantly reduce their risk by having both breasts removed, a procedure known as bilateral prophylactic mastectomy. The risk reduction in the current study was about 95 percent.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack